Condition
Pulmonary Injury
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Terminated1
Completed1
Unknown1
Withdrawn1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05316727Completed
Electronic Nicotine Delivery Devices and Potential Progression to Acute Lung Injury
NCT05414370Not ApplicableUnknown
Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model
NCT04739007Withdrawn
Pulmonary Physiologic Assessment of Patients on Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)
NCT02259452Terminated
Radiation Induced Cardiopulmonary Injury in Humans
Showing all 4 trials